Evaluating biomarkers in metastatic castration-resistant prostate cancer patients treated with enzalutamide: PSA, circulating tumor cell counts, AR-V7 status and radiographic progression.Shruti U. Gandhy, Ravi A. Madan, Fatima Karzai et al.|Journal of Clinical Oncology|2020Cited by 1
Supplementary Data 1 from Correlative Biomarker Analysis of PSMA Expression on CTCs and PSMA Imaging in a Phase I Study of PSMA-Targeted Tubulysin Conjugate EC1169Samir Zaidi, Michael J. Morris, Anthony W. Tolcher et al.|Unknown|2026Cited by 0
Supplementary Figures1 from Correlative Biomarker Analysis of PSMA Expression on CTCs and PSMA Imaging in a Phase I Study of PSMA-Targeted Tubulysin Conjugate EC1169Samir Zaidi, Michael J. Morris, Phillip H. Kuo et al.|Unknown|2026Cited by 0
Supplementary Tables1 from Correlative Biomarker Analysis of PSMA Expression on CTCs and PSMA Imaging in a Phase I Study of PSMA-Targeted Tubulysin Conjugate EC1169Samir Zaidi, Michael J. Morris, Phillip H. Kuo et al.|Unknown|2026Cited by 0
Data from Correlative Biomarker Analysis of PSMA Expression on CTCs and PSMA Imaging in a Phase I Study of PSMA-Targeted Tubulysin Conjugate EC1169Samir Zaidi, Michael J. Morris, Phillip H. Kuo et al.|Unknown|2026Cited by 0